Progeny 3’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
NTCM
Progeny 3's CLBT Position: Q2 2026 in Review
Progeny 3 increased its Cellebrite (CLBT) stake by 77% in Q2 2026, buying an estimated $11.5M and bringing the position to 2,000,000 shares worth $29.2M. The position accounts for 1.51% of the portfolio, ranked #24.
Progeny 3 first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Progeny 3 held 2,000,000 shares of Cellebrite worth $29.2M as of Q2 2026.
- Progeny 3 bought 871,871 Cellebrite shares in Q2 2026, an estimated $11.5M.
- Cellebrite made up 1.51% of Progeny 3's portfolio in Q2 2026, its #24 holding.
- Progeny 3 first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
- 202 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Progeny 3's 13F filing for Q2 2026, filed 14 Aug 2026.